Toxoplasma gondii Ab IgM Test · Blood

Toxoplasma gondii infects roughly a third of the world's population, and most carriers never know it. The parasite hides inside cells, kept in permanent check by a healthy immune system. You can carry it for decades without a single symptom.

But the timing of a new infection can change everything. If you catch Toxoplasma for the first time during pregnancy, the parasite can cross the placenta and damage a developing baby's brain and eyes. If your immune system is weakened by HIV, chemotherapy, or transplant medications, a new or reactivated infection can cause life-threatening brain inflammation. This test looks for the specific antibody, called IgM (immunoglobulin M), that your body produces in the first weeks after a new Toxoplasma encounter. Finding it tells you the infection is recent, which is exactly the information that drives treatment decisions.

How IgM Differs from IgG

Your immune system makes different types of antibodies at different stages of an infection. IgM is the first to appear, typically rising within one to two weeks of a new Toxoplasma infection. It signals that your body has recently encountered the parasite. IgG (immunoglobulin G) appears later, usually a few weeks after IgM, and remains positive for life. A positive IgG with a negative IgM usually means you were infected sometime in the past and now carry lasting immunity.

The distinction matters because a past infection that already triggered IgG protection poses far less risk to a pregnancy or an immunocompromised person than a brand-new infection signaled by IgM. That said, IgM has a well-known interpretive challenge: it can linger in the blood for months or even years after the original infection. A positive IgM does not automatically mean the infection happened last week. Confirming the timing requires additional testing.

Pregnancy and Congenital Toxoplasmosis

Screening pregnant women for Toxoplasma is the single most important use of this test. A global meta-analysis covering data from 71 countries estimated that about 33% of pregnant women worldwide carry IgG antibodies, meaning they were infected at some point in the past. IgM seroprevalence (the share of people who test positive for this antibody, reflecting recent infection) runs much lower, roughly 1% to 2% globally. But even that small percentage translates to tens of thousands of pregnancies each year where acute infection could put a baby at risk.

Congenital toxoplasmosis, where the parasite crosses from mother to baby during pregnancy, can cause vision loss, hearing damage, intellectual disability, and seizures in the child. A Spanish cohort study tracking 56 confirmed congenital infections found that prenatal screening and treatment led to better outcomes for infected newborns, reinforcing the value of catching a new maternal infection early. In a Bangladeshi cohort of 208 pregnant women, Toxoplasma infection during pregnancy was associated with a higher risk of low birth weight. A Czech study of 1,733 pregnancies found that latent toxoplasmosis (measured by IgG, a related but different measurement than IgM) was associated with a modest increase in the risk of prematurity and low birth weight.

If you are planning a pregnancy or are already pregnant, knowing your Toxoplasma status before or early in the first trimester gives you the most options. A negative IgG and IgM means you have never been exposed and should take precautions to avoid infection during pregnancy. A positive IgG with a negative IgM means you were infected in the past and likely have protective immunity. A positive IgM is the result that triggers urgent follow-up to determine timing.

Mental Health Associations

Several studies have linked Toxoplasma infection to psychiatric conditions, though the evidence is still being refined. Most of these studies used IgG (measuring past infection) rather than IgM specifically, so they reflect latent rather than acute infection. A large cross-sectional study of 7,141 people in China found that Toxoplasma seropositivity (IgG-based) was significantly more common in people with mania, schizophrenia, depression, recurrent depressive disorder, and bipolar disorder.

A meta-analysis pooling data across multiple countries found that Toxoplasma infection was associated with schizophrenia and bipolar disorder, with some evidence suggesting that reactivation of latent infection may play a role in psychotic relapses. A separate meta-analysis focusing specifically on IgM in acute psychosis found an increased prevalence of Toxoplasma IgM antibodies in patients experiencing acute psychotic episodes, suggesting that some relapses may coincide with recent infection or reactivation. A case-control study of 230 participants linked latent toxoplasmosis (IgG-based) to bipolar disorder risk. And a meta-analysis of suicide risk found that Toxoplasma-infected individuals had about 43% higher odds of suicide attempts compared to uninfected individuals.

These associations are real and consistent across studies, but they do not prove that Toxoplasma causes psychiatric illness. The parasite forms cysts in brain tissue and can alter the brain's chemical signaling systems, making a biological link plausible. But many other factors influence mental health. If you have a psychiatric condition and test IgM-positive, this finding is worth discussing with both an infectious disease specialist and your psychiatrist.

Brain Tumor Risk

A meta-analysis of seven studies covering 2,323 brain tumor cases and 5,131 controls found that people with evidence of Toxoplasma exposure had roughly twice the odds of developing a brain tumor compared to unexposed individuals. The association was observed for glioma, the most common primary brain cancer in adults. Two prospective studies using pre-diagnosis blood samples found that high antibody levels against a specific Toxoplasma surface protein (called sag-1) were associated with about 79% higher glioma risk.

These findings are based on general Toxoplasma antibodies and IgG, not IgM specifically. They suggest that past exposure, rather than acute infection, may be the relevant factor. This area of research is still developing, and a Toxoplasma IgM test is not a cancer screening tool. But the brain tumor data add to the broader picture of why knowing your Toxoplasma status has value beyond pregnancy.

Cardiovascular Risk

A large U.S. cohort study using NHANES data followed 10,237 adults for a median of 8 years. Men who tested positive for Toxoplasma IgG (a related measurement indicating past infection, not IgM) had about 40% higher risk of dying from cardiovascular disease compared to uninfected men, after adjusting for standard risk factors like blood pressure, cholesterol, smoking, and kidney function. This association was not seen in women. A separate study of 694 adults found that people with latent Toxoplasma infection (IgG-positive) had roughly 11% higher levels of a blood vessel inflammation marker called VCAM-1 (vascular cell adhesion molecule), which signals damage to artery walls.

Again, these cardiovascular findings are tied to IgG (latent infection), not IgM. No study in the available research links IgM-detected acute infection directly to heart attack or stroke risk. But the IgG data suggest that long-term Toxoplasma carriage may contribute to chronic inflammation that affects blood vessels, which is another reason to establish your infection status.

Interpreting Your Result

This test reports a qualitative result: positive, negative, or equivocal (also called indeterminate or borderline). The exact cutoff values vary by lab and assay platform, so there is no single universal number. What matters is the category your result falls into.

Different commercial assays (the lab instruments used to run the test) vary in how sensitive they are. A multicenter European study comparing the LIAISON automated system found IgM sensitivity of 96.7% and specificity of 95.4%. A large French multicenter comparison of several assay platforms, using the ISAGA method as a reference standard, showed that ISAGA-based IgM detection had 98.7% sensitivity in adults, while an ELISA-based alternative (Platelia IgM) had 94.4% sensitivity but flagged many more false positives when measured against the ISAGA reference. This means some platforms are better than others at avoiding false positives. If your IgM result is positive, consider which assay your lab used before acting on the result.

When Results Can Be Misleading

The most common problem with Toxoplasma IgM is a false sense of urgency. A positive IgM can persist for months to years after the original infection, meaning a positive result does not reliably tell you when you were infected. In pregnant women, this ambiguity can lead to unnecessary anxiety, invasive testing, or even consideration of pregnancy termination when the infection actually occurred well before conception and poses no fetal risk.

• Persistent IgM: Some people retain low-level IgM for a year or more after infection. An isolated positive IgM without supporting evidence of recent seroconversion should not be treated as proof of acute infection.
• Autoimmune antibodies: Rheumatoid factor (an autoimmune protein) and antinuclear antibodies (ANA, immune proteins that mistakenly attack your own cells) can cause false-positive IgM results on certain assay platforms.
• Other acute infections: A different viral or bacterial infection happening at the same time can occasionally trigger nonspecific IgM reactivity that mimics a Toxoplasma-positive result.
• Immunosuppression: People with severely weakened immune systems (advanced HIV, post-transplant) may fail to produce IgM even during active infection, leading to false-negative results. In these cases, PCR (a DNA-based test that directly detects the parasite's genetic material) is more reliable than antibody testing.

Why a Single Reading Is Not Enough

A single Toxoplasma IgM result, whether positive or negative, rarely tells the full story. The real value comes from interpreting IgM alongside IgG and, when needed, IgG avidity (a measure of how tightly IgG antibodies bind to the parasite, which increases over time after infection). A systematic review of diagnostic strategies in pregnant women found that combining IgM, IgG avidity, and IgA testing significantly improved the accuracy of diagnosing recent versus past infection.

If you are testing proactively before pregnancy, the most useful approach is to establish a baseline: get both IgG and IgM checked. If both are negative, you know you have never been exposed and should avoid raw meat, unwashed produce, and cat litter contact during pregnancy. If IgG is positive and IgM is negative, you were infected in the past and likely have protective immunity. If IgM is positive, follow-up testing with IgG avidity will clarify timing.

What to Do with an Abnormal Result

A positive or equivocal IgM result should trigger a clear sequence of next steps, not panic. First, request IgG testing from the same blood draw if it was not already ordered. If IgG is negative and IgM is positive, retest both in two to three weeks to see if IgG is seroconverting (appearing for the first time), which would confirm a genuinely new infection.

If both IgG and IgM are positive, add an IgG avidity test. High avidity (strong antibody binding) indicates the infection happened more than three to four months ago, even if IgM is still lingering. Low avidity with positive IgM strongly suggests a recent infection. In pregnant women with confirmed recent infection, referral to a maternal-fetal medicine specialist or infectious disease physician is appropriate to discuss amniocentesis (sampling fluid from around the baby) for fetal PCR testing and potential treatment with spiramycin or pyrimethamine-sulfadiazine.

For immunocompromised individuals, a positive IgM with clinical symptoms (headache, confusion, fever, vision changes) should prompt urgent evaluation including brain imaging and PCR testing of blood or spinal fluid. Even a negative IgM in a severely immunosuppressed person does not rule out active toxoplasmosis, because the weakened immune system may fail to produce antibodies.